文献速递产科母胎医学

妊娠期2019冠状病毒病的流行病学:危险因素及与不良母婴结局的关联

Epidemiology of coronavirus disease 2019 in pregnancy: risk factors and associations with adverse maternal and neonatal outcomes.
PubMed 文献 · Am J Obstet Gynecol · 2020-09-25

该匹配病例对照研究纳入2020年3月11日至6月11日分娩的61例确诊COVID-19孕妇与按2:1匹配的未感染孕妇,发现病例组不良母体复合结局的比值是对照组的3.4倍(18.0% vs 8.2%;调整OR 3.4;95%CI 1.2-13.4),不良新生儿复合结局的比值是对照组的1.7倍(18.0% vs 13.9%;调整OR 1.7;95%CI 0.8-4.8),关联主要由重症或危重症驱动。

要点

  • 确诊COVID-19孕妇不良母体复合结局风险升高(调整OR 3.4;95%CI 1.2-13.4)。
  • 不良新生儿复合结局风险未达统计学显著(调整OR 1.7;95%CI 0.8-4.8)。
  • 黑人及西班牙裔种族、高龄、合并症和COVID-19相关产前入院是主要危险因素。

核心结论

  • 妊娠期COVID-19与不良母婴结局风险增加相关,该关联主要由重症或危重症COVID-19所致。
  • 黑人及西班牙裔种族、肥胖、高龄、合并症和COVID-19相关产前入院是相关 morbidity 的危险因素。

研究设计与样本

  • 匹配病例对照研究,纳入2020年3月11日至6月11日分娩的妊娠16至41周确诊COVID-19孕妇61例,未感染对照按分娩日期2:1匹配。
  • 采用条件logistic回归进行未调整和调整分析,效应量为匹配对OR及基于1000次偏差校正bootstrap重采样的95%CI。

主要发现

  • 病例组轻症54例(88.5%)、重症6例(9.8%)、危重症1例(1.6%)。
  • 不良母体复合结局:病例组18.0% vs 对照组8.2%;调整OR 3.4(95%CI 1.2-13.4)。
  • 不良新生儿复合结局:病例组18.0% vs 对照组13.9%;调整OR 1.7(95%CI 0.8-4.8),未达统计学显著。
  • 按疾病严重程度分层分析表明,妊娠期COVID-19相关 morbidity 主要由重症或危重症表型驱动。

临床怎么用

  • 作者指出,妊娠期COVID-19与不良母婴结局风险增加相关,该关联主要由重症或危重症COVID-19所致。
  • 作者指出,黑人及西班牙裔种族、肥胖、高龄、合并症和COVID-19相关产前入院是相关 morbidity 的危险因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Coronavirus disease 2019 may be associated with adverse maternal and neonatal outcomes in pregnancy, but there are few controlled data to quantify the magnitude of these risks or to characterize the epidemiology and risk factors. OBJECTIVE: This study aimed to quantify the associations of coronavirus disease 2019 with adverse maternal and neonatal outcomes in pregnancy and to characterize the epidemiology and risk factors. STUDY DESIGN: We performed a matched case-control study of pregnant patients with confirmed coronavirus disease 2019 cases who delivered between 16 and 41 weeks' gestation from March 11 to June 11, 2020. Uninfected pregnant women (controls) were matched to coronavirus disease 2019 cases on a 2:1 ratio based on delivery date. Maternal demographic characteristics, coronavirus disease 2019 symptoms, laboratory evaluations, obstetrical and neonatal outcomes, and clinical management were chart abstracted. The primary outcomes included (1) a composite of adverse maternal outcome, defined as preeclampsia, venous thromboembolism, antepartum admission, maternal intensive care unit admission, need for mechanical ventilation, supplemental oxygen, or maternal death, and (2) a composite of adverse neonatal outcome, defined as respiratory distress syndrome, intraventricular hemorrhage, necrotizing enterocolitis, 5-minute Apgar score of <5, persistent category 2 fetal heart rate tracing despite intrauterine resuscitation, or neonatal death. To quantify the associations between exposure to mild and severe or critical coronavirus disease 2019 and adverse maternal and neonatal outcomes, unadjusted and adjusted analyses were performed using conditional logistic regression (to account for matching), with matched-pair odds ratio and 95% confidence interval based on 1000 bias-corrected bootstrap resampling as the effect measure. Associations were adjusted for potential confounders. RESULTS: A total of 61 confirmed coronavirus disease 2019 cases were enrolled during the study period (mild disease, n=54 [88.5%]; severe disease, n=6 [9.8%]; critical disease, n=1 [1.6%]). The odds of adverse composite maternal outcome were 3.4 times higher among cases than controls (18.0% vs 8.2%; adjusted odds ratio, 3.4; 95% confidence interval, 1.2-13.4). The odds of adverse composite neonatal outcome were 1.7 times higher in the case group than to the control group (18.0% vs 13.9%; adjusted odds ratio, 1.7; 95% confidence interval, 0.8-4.8). Stratified analyses by disease severity indicated that the morbidity associated with coronavirus disease 2019 in pregnancy was largely driven by the severe or critical disease phenotype. Major risk factors for associated morbidity were black and Hispanic race, advanced maternal age, medical comorbidities, and antepartum admissions related to coronavirus disease 2019. CONCLUSION: Coronavirus disease 2019 during pregnancy is associated with an increased risk of adverse maternal and neonatal outcomes, an association that is primarily driven by morbidity associated with severe or critical coronavirus disease 2019. Black and Hispanic race, obesity, advanced maternal age, medical comorbidities, and antepartum admissions related to coronavirus disease 2019 are risk factors for associated morbidity.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Brandt JS, Hill J, Reddy A, et al. Epidemiology of coronavirus disease 2019 in pregnancy: risk factors and associations with adverse maternal and neonatal outcomes. Am J Obstet Gynecol. 2020. PMID: 32986989. doi:10.1016/j.ajog.2020.09.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。